Author

Jeremy Michael Kinder

Cincinnati Children's Hospital Medical CenterORCID 0000-0001-5145-1344Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alicia Ramiriqui· 1 shared Emily M. EshlemaniD· 1 shared Erica Culberson· 1 shared Faris N. Al GharaibehiD· 1 shared Gloria PryhuberiD· 1 shared Hitesh S. DeshmukhiD· 1 shared Jerilyn K. GrayiD· 1 shared Joseph StevensiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alicia Ramiriqui

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Microbiota-derived inosine programs protective CD8+ T cell responses against influenza in newborns

Joseph Stevens, Erica Culberson, Jeremy Michael Kinder, Alicia Ramiriqui, Jerilyn K. Gray, Madeline Bonfield, Tzu‐Yu Shao, Faris N. Al Gharaibeh, Laura S. Peterson, Shelby H. Steinmeyer, Emily M. Eshleman, Shikha Negi, William J. Zacharias, Gloria Pryhuber, Oindrila Paul, , Hitesh S. Deshmukh

This study identifies microbiota-derived inosine as a key factor in promoting CD8+ T cell responses against influenza in newborns by reversing epigenetic dysregulation.

Cell · Jan 1, 2024Peer-reviewedImmunology